Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling

Area of Science:

• Neuro-oncology
• Cancer Stem Cell Biology
• Genomics

Background:

• Glioblastoma (GBM) is an aggressive brain tumor characterized by significant heterogeneity.
• Glioma stem cells (GSCs) are implicated in tumor recurrence and exhibit variable drug sensitivity.
• Intratumoral heterogeneity in GSCs is not well understood.

Purpose of the Study:

• To investigate the extent of heterogeneity within GSC cultures derived from different regions of a single GBM tumor.
• To compare intratumoral GSC heterogeneity with interpatient GSC heterogeneity.
• To assess the impact of GSC heterogeneity on drug sensitivity patterns.

Main Methods:

• Established seven GSC cultures from spatially distinct biopsies of a single GBM tumor.
• Compared phenotype, proliferation, gene expression, mutations, and drug sensitivity (115 drugs) of multiregional GSC cultures.
• Contrasted findings with 14 GSC cultures from other GBM patients.

Main Results:

• GSC cultures from a single tumor showed minor differences in phenotype and global gene expression.
• Significant intratumoral heterogeneity was observed in mutational profiles and drug sensitivity.
• Intratumoral heterogeneity was comparable to the heterogeneity found between GSC cultures from different GBM patients.

Conclusions:

• A single GBM biopsy may not capture the full complexity of the GSC population.
• GSC cultures from multiple tumor regions are essential for comprehensive drug screening.
• Understanding intratumoral heterogeneity is critical for developing effective GBM therapies.